Assembly Biosciences (ASMB) Assets Average (2011 - 2026)

Assembly Biosciences' Assets Average history runs 16 years deep, the most recent figure standing at $246.5 million for Q1 2026.

• In Q1 2026, Assets Average rose 126.0% year-over-year to $246.5 million; the TTM figure through Mar 2026 stood at $246.5 million (up 126.0% YoY), while the FY2025 annual figure was $188.4 million, up 47.18% from the prior year.
• Assets Average was $246.5 million for Q1 2026 at Assembly Biosciences, down from $248.8 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $248.8 million in Q4 2025 to a low of $59.1 million in Q3 2023.
• Historically, Assets Average has averaged $130.2 million across 5 years, with a median of $111.7 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Assets Average plunged 55.39% in 2023, then jumped 126.76% in 2025.
• A 5-year view of Assets Average shows it stood at $111.7 million in 2022, then fell by 15.61% to $94.2 million in 2023, then advanced by 16.44% to $109.7 million in 2024, then soared by 126.76% to $248.8 million in 2025, then slipped by 0.9% to $246.5 million in 2026.
• The last three Assets Average figures came in at $246.5 million (Q1 2026), $248.8 million (Q4 2025), and $160.4 million (Q3 2025), per Business Quant data.